10.60 USD
↘ 0.05 (0.47%)AT CLOSE (11:59 AM EDT)
Daxor Corporation Common Stock
DXRNASDAQ • USD
10.57
↘ 0.03 (0.28%)
POST MARKET (AS OF 04:16 PM EDT)
Post Market
AS OF 04:16 PM EDT
10.57
↘ 0.03 (0.28%)
Market: CLOSED
Daxor Corporation Common Stock (DXR) trades at $10.65 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. DXR is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 15, 2026.
Open?$11.15
High?$11.19
Low?$10.60
Prev. Close?$10.65
Volume?1.8K
Avg. Volume?2.3K
VWAP?$10.81
Rel. Volume?0.80x
Bid / Ask
Bid?$10.11 × 100
Ask?$12.24 × 100
Spread?$2.13
Midpoint?$11.18
Valuation & Ratios
Market Cap?62.2M
Shares Out?5.8M
Float?2.0M
Float %?40.5%
P/E Ratio?N/A
P/B Ratio?1.72
EPS?-$0.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Employees
750
Market Cap
62.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
1983-07-25
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: (212) 244-0555
NEW YORK, NY 10118
Phone: (212) 244-0555
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?19
Momentum?17
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?1.43Distress
Confidence?30%Very Low
Short InterestLow
Short % of Float?0.06%Low
Short Interest?1.3K
Days to Cover?1.0
Free Float2.0M
Avg Daily Volume3.1K
Settlement Date2026-06-30
Financial Health
Current Ratio?1.66Adequate
Quick Ratio?1.65Adequate
Cash Ratio?0.00Low
Debt/Equity?1.03Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.72CHEAP▾
Peers100
S&P82
P/S?43.47HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-20.2CHEAP▾
S&P97
EV/Sales?69.43HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-9.9%WEAK▾
S&P9
ROA?-4.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$99.3M
Fundamentals ratios updated end of day